Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Equity Average: 2009-2025

Historic Equity Average for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Sep 2025 value amounting to $27.1 million.

  • Cumberland Pharmaceuticals' Equity Average rose 5.83% to $27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.1 million, marking a year-over-year increase of 5.83%. This contributed to the annual value of $26.2 million for FY2024, which is 20.36% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Equity Average is $27.1 million, which was down 4.48% from $28.3 million recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Equity Average peaked at $47.5 million during Q2 2021, and registered a low of $23.8 million during Q4 2024.
  • Its 3-year average for Equity Average is $29.9 million, with a median of $28.3 million in 2025.
  • In the last 5 years, Cumberland Pharmaceuticals' Equity Average slumped by 30.11% in 2024 and then rose by 5.83% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Equity Average (Quarterly) stood at $44.8 million in 2021, then declined by 16.29% to $37.5 million in 2022, then fell by 12.58% to $32.8 million in 2023, then declined by 27.38% to $23.8 million in 2024, then climbed by 5.83% to $27.1 million in 2025.
  • Its last three reported values are $27.1 million in Q3 2025, $28.3 million for Q2 2025, and $25.8 million during Q1 2025.